Latest News about Biotech
Recent news which mentions Biotech
Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits
December 19, 2024
From Benzinga
EXCLUSIVE: MIRA Pharmaceuticals Files FDA Application To Start Human Trials For Its Lead Pain Treatment
December 19, 2024
From Benzinga
EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia
December 19, 2024
From Benzinga
Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges
December 19, 2024
From Benzinga
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
December 18, 2024
From Benzinga
Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday?
December 18, 2024
From Benzinga
What's Going On With Viking Therapeutics Stock On Wednesday?
December 18, 2024
From Benzinga
Novo Nordisk's Ozempic Under Scrutiny For Potential Increased Risk Of Rare-Eye Disease
December 18, 2024
From Benzinga
Why Is Penny Stock Cognition Therapeutics Trading Over 93% On Wednesday?
December 18, 2024
From Benzinga
EXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend
December 18, 2024
From Benzinga
Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval
December 17, 2024
From Benzinga
From Benzinga
From Benzinga
Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside
December 17, 2024
From Benzinga
What's Going On With Larimar Therapeutics Stock On Tuesday?
December 17, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.